CRISPR Technique Shown to Be Effective Tool against Colitishttps://www.genengnews.com/news/crispr-technique-shown-to-be-effective-tool-against-colitis/
2020-03 In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials
In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials | mBiohttps://mbio.asm.org/content/11/2/e00019-20
2020-03 In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials
Study Shows CRISPR Effectiveness Against Colitis Pathogen | NC State Newshttps://news.ncsu.edu/2020/03/crispr-kills-pathogen/
2020-03 In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials

Showing topic

2020-03 In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials
Cas3